StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
XNCR

Xencor, Inc.

XNCR Nasdaq Pharmaceutical Preparations EDGAR ↗
$19.40
-2.09 -9.73%

Key statistics

from XBRL data in SEC filings
Market cap
$1.44B
Revenue (TTM)
$97.4M
Net income (TTM)
-$172M
EPS (TTM)
$-2.29
P/E ratio
Dividend yield
Free cash flow
-$138M
Cash
$14.2M
Total assets
$737M
Gross margin
52-week range
$6.92 – $21.76

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure Jul 29, 2026 8-K Shareholder vote results Jun 18, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 8-K Regulation FD disclosure May 5, 2026 8-K Director or officer change Apr 27, 2026 8-K Terminated a material agreement Mar 9, 2026 8-K Regulation FD disclosure Mar 4, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Results of operations (earnings release) Feb 25, 2026 8-K Results of operations (earnings release) Jan 8, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Regulation FD disclosure Oct 24, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Director or officer change Jul 31, 2025 8-K Shareholder vote results Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release); Director or officer change May 7, 2025 8-K Regulation FD disclosure Apr 30, 2025 8-K/A Changed accountants Mar 13, 2025 8-K Director or officer change Mar 13, 2025 8-K Changed accountants Mar 5, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 10-Q/A Quarter ended 2024-09-30 Feb 24, 2025 10-Q/A Quarter ended 2024-06-30 Feb 24, 2025 10-Q/A Quarter ended 2024-03-31 Feb 24, 2025 10-K/A Fiscal year ended 2023-12-31 Feb 24, 2025 8-K Previously issued financials not reliable Feb 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Director or officer change Oct 4, 2024 8-K Other events Sep 12, 2024 8-K Entered a material agreement; Other events Sep 12, 2024 8-K Regulation FD disclosure; Other events Sep 9, 2024 10-Q Quarter ended 2024-06-30 Aug 5, 2024 8-K Results of operations (earnings release) Aug 5, 2024